Active Biotech AB Net Asset Quality Index
Active Biotech AB net asset quality index. Active Biotech AB (ACTI) has a Net Asset Quality Index of 77.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr47.90 Million minus total liabilities of Skr10.70 Million yields net assets of Skr37.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Active Biotech AB (ACTI) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Active Biotech AB (2000–2025)
Net asset quality index of Active Biotech AB from 2000 to 2025. This chart shows how Active Biotech AB's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 77.7%, representing net assets of Skr37.20 Million against total assets of Skr47.90 Million SEK. Check ACTI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Active Biotech AB Net Asset Quality Index by Year (2000–2025)
Active Biotech AB net asset quality index by year from 2000 to 2025. The table below presents the year-by-year Net Asset Quality Index for Active Biotech AB from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Active Biotech AB market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.2% | Skr55.60 Million | Skr70.20 Million | Skr14.60 Million | ▲ +5.0 pp |
| 2024 | 74.2% | Skr32.07 Million | Skr43.20 Million | Skr11.13 Million | ▲ +4.6 pp |
| 2023 | 69.6% | Skr30.67 Million | Skr44.05 Million | Skr13.38 Million | ▲ +2.0 pp |
| 2022 | 67.7% | Skr34.51 Million | Skr51.01 Million | Skr16.49 Million | ▼ -14.5 pp |
| 2021 | 82.2% | Skr46.67 Million | Skr56.80 Million | Skr10.13 Million | ▲ +13.4 pp |
| 2020 | 68.8% | Skr22.11 Million | Skr32.16 Million | Skr10.04 Million | ▼ -11.6 pp |
| 2019 | 80.3% | Skr53.78 Million | Skr66.95 Million | Skr13.17 Million | ▲ +51.3 pp |
| 2018 | 29.1% | Skr87.92 Million | Skr302.43 Million | Skr214.52 Million | ▲ +3.5 pp |
| 2017 | 25.6% | Skr77.68 Million | Skr303.81 Million | Skr226.14 Million | ▼ -18.6 pp |
| 2016 | 44.2% | Skr182.56 Million | Skr412.88 Million | Skr230.32 Million | ▲ +4.0 pp |
| 2015 | 40.2% | Skr180.60 Million | Skr449.44 Million | Skr268.84 Million | ▼ -15.9 pp |
| 2014 | 56.1% | Skr405.31 Million | Skr722.52 Million | Skr317.21 Million | ▲ +3.3 pp |
| 2013 | 52.8% | Skr405.41 Million | Skr767.81 Million | Skr362.40 Million | ▲ +4.0 pp |
| 2012 | 48.8% | Skr339.92 Million | Skr696.74 Million | Skr356.82 Million | ▼ -9.7 pp |
| 2011 | 58.5% | Skr501.99 Million | Skr858.52 Million | Skr356.53 Million | ▲ +22.3 pp |
| 2010 | 36.1% | Skr181.76 Million | Skr503.10 Million | Skr321.34 Million | ▼ -1.7 pp |
| 2009 | 37.8% | Skr188.64 Million | Skr498.50 Million | Skr309.86 Million | ▲ +3.2 pp |
| 2008 | 34.6% | Skr163.61 Million | Skr472.95 Million | Skr309.34 Million | ▼ -4.1 pp |
| 2007 | 38.7% | Skr189.57 Million | Skr489.54 Million | Skr299.97 Million | ▲ +25.7 pp |
| 2006 | 13.1% | Skr60.36 Million | Skr462.40 Million | Skr402.04 Million | ▼ -18.1 pp |
| 2005 | 31.1% | Skr176.81 Million | Skr567.86 Million | Skr391.05 Million | ▼ -20.7 pp |
| 2004 | 51.9% | Skr162.30 Million | Skr312.89 Million | Skr150.59 Million | ▼ -32.0 pp |
| 2003 | 83.8% | Skr289.58 Million | Skr345.40 Million | Skr55.82 Million | ▲ +2.5 pp |
| 2002 | 81.3% | Skr380.27 Million | Skr467.50 Million | Skr87.24 Million | ▼ -9.4 pp |
| 2001 | 90.8% | Skr678.78 Million | Skr747.74 Million | Skr68.96 Million | ▲ +16.4 pp |
| 2000 | 74.3% | Skr646.03 Million | Skr868.95 Million | Skr222.92 Million | — |